The production of gamma interferon (IFN-␥) is a key step in the protective innate immune response to Francisella tularensis. Natural killer cells and T cells in the liver are important sources of this cytokine during primary F. tularensis infections, and interleukin-12 (IL-12) appears to be an essential coactivating cytokine for hepatic IFN-␥ expression. The present study was undertaken to determine whether or not macrophages (M) or dendritic cells (DC) provide coactivating signals for the liver IFN-␥ response in vitro, whether IL-12 mediates these effects, and whether Toll-like receptor (TLR) signaling is essential to induce this costimulatory activity. Both bone marrow-derived M and DC significantly augmented the IFN-␥ response of F. tularensischallenged liver lymphocytes in vitro. While both cell types produced IL-12p40 in response to F. tularensis challenge, only DC secreted large quantities of IL-12p70. DC from both IL-12p35-deficient and TLR2-deficient mice failed to produce IL-12p70 and did not costimulate liver lymphocytes for IFN-␥ production in response to viable F. tularensis organisms. Conversely, liver lymphocytes from TLR2-deficient mice cocultured with wild-type accessory cells produced IFN-␥ at levels comparable to those for wild-type hepatic lymphocytes. These findings indicate that TLR2 controls hepatic lymphocyte IFN-␥ responses to F. tularensis by regulating DC IL-12 production. While M also coinduced hepatic IFN-␥ production in response to F. tularensis, they did so in a fashion less dependent on TLR2.
Francisella tularensis is a highly infectious, gram-negative, facultative intracellular bacterium and the etiological agent of tularemia. Transmission of this zoonotic infection to human beings can occur through insect bites (ticks, flies, and mosquitoes), cutaneous contact with infected animal carcasses, ingestion of contaminated food and water, or inhalation of aerosolized viable organisms (21, 32) . Over 50 years ago, an attenuated live vaccine strain (LVS) of the bacterium was developed by serial passage of a type B F. tularensis (subsp. holarctica) strain (18, 35) , but the vaccine is no longer licensed for general use. Despite being attenuated for humans, the LVS strain is virulent in mice and causes pneumonia and systemic disease in mice that closely resembles that seen in human tularemia (2, 19) . For this reason, infection of mice with F. tularensis LVS has been the preferred animal model for characterizing the pathophysiological processes that accompany infection and identifying correlates of protective immunity to the pathogen (19) . Regardless of the route of infection in mice, F. tularensis LVS establishes secondary infections in the liver, lungs, and spleen, where the organism appears to infect and replicate within macrophages (M), hepatocytes, dendritic cells (DC), and type II lung epithelial cells (3, 5, 12, 14, 24) . In immunologically naïve and immune mice, several mediators of immune protection against F. tularensis LVS have been consistently identified in various infection models. In particular, the production of the Th1 cytokines interleukin-12 (IL-12), gamma interferon (IFN-␥), and tumor necrosis factor alpha (TNF-␣) appears to be important for limiting the growth of the organism and resolving infections (2, 6, 11, 13, 15, 20, 22, 27) .
Pattern recognition is a common feature of innate immunity to microbial pathogens. Among the known cell surface pattern recognition receptors, members of the Toll-like receptor (TLR) family play a central role in sensing the presence of infectious pathogens. Individual TLR family members vary, not only in their cellular distribution and ligand specificity but also in the nature of the intracellular signaling pathways they use to activate transcription of specific subsets of host genes (37) . An important adapter protein, MyD88, mediates intracellular signaling by many of the TLRs and is indispensable for initiating protective innate immune responses in mice following primary intradermal challenge with F. tularensis LVS (11, 26, 28, 31) . There is less certainty about which specific TLRs play essential roles in the recognition of F. tularensis LVS in the mouse. The lipopolysaccharides of F. tularensis LVS and other F. tularensis subspecies show relatively weak endotoxic activity (1, 16, 23, 33) and fail to act as either TLR agonists or antagonists (1, 16, 23) . Altered receptor binding probably explains the relatively minor role TLR4 plays in initiating inflammatory responses to a number of F. tularensis stains (7, 8, 11, 26, 28) . Indeed, most investigators now agree that TLR4-mediated signaling is not a major pathway for inducing immune and inflammatory responses to F. tularensis LVS.
Increasing evidence suggests that TLR2 is involved in the recognition of F. tularensis LVS by cells of the mouse innate immune system. TLR2 appears to mediate the induction of TNF-␣, IL-1␤, IL-6, M inflammatory protein 1␣, and M inflammatory protein 2 by mouse bone marrow-derived M and DC that have been challenged with F. tularensis LVS in vitro (26, 28, 31) , and peritoneal M from TLR2-deficient mice are unresponsive to F. tularensis LVS compared to wildtype M (10) . Increased expression of costimulatory molecules on mouse DC after exposure to F. tularensis LVS also appears to be TLR2 dependent (26) . Despite these observations, the role of TLR2 in determining the overall course of infection is less clear. Malik et al. (31) reported that TLR2-deficient mice showed impaired bacterial clearance from their livers, lungs, and spleens after intranasal challenge with a sublethal dose of F. tularensis LVS and succumbed to a 10-fold lower challenge dose than wild-type mice. By contrast, Collazo et al. (11) reported that TLR2-deficient mice were no more susceptible than wild-type mice to intradermal challenge with F. tularensis LVS, even though MyD88-deficient mice were extremely susceptible to intradermal infection with the pathogen. Thus, the role of individual TLR in initiating essential responses to F. tularensis LVS may vary depending on the route of infection and the nature of host cells mediating protective immune responses at a particular site.
The mouse liver is consistently colonized with F. tularensis LVS regardless of the route of infection and is the dominant site for many of the innate immune responses to the pathogen (9) . For these reasons, we have recently begun a systematic study of hepatic innate immunity to F. tularensis LVS in mice. Large numbers of hepatic natural killer (NK) cells are activated for IFN-␥ expression during infection with F. tularensis LVS by the intraperitoneal route, and hepatic mononuclear cells (HMC) produce IFN-␥ in response to F. tularensis LVS challenge in vitro (38) . The IFN-␥ response that is elicited in lymphocyte cultures is mediated, in large part, by NK cells. This response requires the production of IL-12, as evidenced by the inability of HMC from IL-12p35-deficient mice to produce IFN-␥ following challenge with F. tularensis LVS (38) .
The present study was designed to address several features of the hepatic lymphocyte IFN-␥ response to F. tularensis LVS. First, we wished to know to what extent M or DC could provide coactivating signals for liver lymphocyte IFN-␥ responses to the pathogen and whether IL-12 mediated the effects of either of these accessory cell populations. Second, we asked whether or not TLR2 mediates the recognition of F. tularensis LVS in this context and in which cell type the receptor functions. The results of this study suggest that TLR2 plays an essential role in the recognition of F. tularensis LVS by DC and regulates the production of IFN-␥ in the liver by controlling IL-12 and IL-18 production.
MATERIALS AND METHODS
Reagents. Recombinant mouse IL-12 and granulocyte-M colony-stimulating factor (GM-CSF) were purchased from R&D Systems (Minneapolis, MN). Recombinant mouse IL-18 was from Invitrogen (Carlsbad, CA). Neutralizing rat anti-mouse IL-12p40/p70 was obtained from BD Biosciences (San Jose, CA), and rat anti-mouse IL-18 was purchased from MBL International (Woburn, MA). Normal rat immunoglobulin G2a kappa (BD Biosciences) was used as a negative control for the antibody neutralization studies. Paired OptEIA antibody sets and cytokine standards for the detection of mouse IFN-␥, IL-12p40, and IL-12p70 were purchased from BD Biosciences. The paired antibodies for measuring IL-18 were from MBL International.
Mice. Six-week-old female C57BL/6J (B6) mice purchased from Jackson Laboratories (Bar Harbor, ME) were used from 7 to 12 weeks of age throughout this study. Immunodeficient mutants on the B6 background (Jackson Laboratories) included the IL-12p35-deficient B6. (38) . Frozen aliquots were stored at Ϫ70°C, thawed rapidly prior to use, washed once in Dulbecco's phosphate-buffered saline, and resuspended in antibiotic-free RPMI medium containing 2 mM L-glutamine and 10% heat-inactivated fetal bovine serum (FBS). Multiplicities of infection (MOI) were determined by serial dilution of bacterial suspensions and inoculation onto chocolate agar plates.
Bone marrow-derived M and DC. Mouse bone marrow-derived M and DC were prepared by slight modifications of previously published techniques (30, 38) . To prepare M, bone marrow cells were flushed from the femurs of wildtype or mutant mice, counted, and grown in 75-cm 2 tissue culture flasks in M growth medium (Dulbecco's modified Eagle's medium, 3.7 g/liter NaHC0 3 , 10 mM HEPES, 7% L-cell-conditioned medium, 10% FBS, penicillin, and streptomycin). The cells were grown for 12 days in an atmosphere of 10% CO 2 , with the M growth medium being replaced after 7 days. Over 95% of the resulting M expressed F4/80, as determined by flow cytometry. The adherent M were dislodged from the flasks by treatment with 0.25% trypsin-EDTA for 5 min, resuspended in M growth medium, and transferred to 96-well plates. After overnight incubation to allow attachment of the cells, M growth medium was replaced with antibiotic-free complete tissue culture medium (RPMI 1640, 10 mM HEPES, 10% FBS), and the cultures were transferred to an atmosphere of 5% CO 2 . Some cultures then also received HMC and F. tularensis LVS, while other M cultures were challenged directly with bacteria.
For the preparation of DC, bone marrow cells were grown in DC medium (RPMI 1640, 10 mM HEPES, 10% FBS, 10 M 2-mercaptoethanol, 20 ng/ml GM-CSF, penicillin, and streptomycin) in 60-mm-diameter bacteriological dishes in an atmosphere of 5% CO 2 . After the initial 2 days of culture, an equal volume of fresh DC medium was added. On days 4, 6, and 8, most of the medium was removed from each culture and centrifuged at 300 ϫ g for 8 min. The cell pellet was then resuspended in fresh DC medium, and the cells were returned to their original dishes. On day 10, the nonadherent DC were again removed, washed, resuspended in fresh DC medium containing 10 ng of GM-CSF per ml, and returned to their original dishes. Incubation was continued for an additional 2 days. The resulting nonadherent DC were 75 to 95% CD11c ϩ B220 Ϫ , as determined by flow cytometry. Nonadherent DC were washed once to remove DC medium and resuspended in antibiotic-free complete tissue culture medium prior to their addition to 96-well plates on the morning of the experiment. The plates were then incubated at 37°C in an atmosphere of 5% CO 2 .
Lymphocyte and accessory cell cultures. HMC were prepared as previously described (38) , by digesting mouse livers with a mixture of Liberase (Roche, Indianapolis, IN) and DNase and centrifuging the resulting cell suspension through 28% Percoll (GE Healthcare, Piscataway, NJ). The erythrocytes that passed through the Percoll were lysed with ACK lysis buffer (Cambrex, Walkersville, MD). The washed HMC preparation contained lymphocytes, M, DC, and an occasional hepatocyte and was resuspended in antibiotic-free complete tissue culture medium. The cells were then plated at a concentration of 200,000 cells per well in flat-bottom 96-well tissue culture plates and incubated at 37°C in an atmosphere of 5% CO 2 . To assess the ability of accessory cells to coactivate HMC for IFN-␥ production, the HMC were added to wells that already contained bone marrow-derived M or DC. To assess their ability to produce IL-12, cultures of M or DC were challenged with bacteria in the absence of HMC.
Thawed aliquots of F. tularensis LVS were washed in phosphate-buffered saline and resuspended in antibiotic-free medium. They were then added to HMC, M, or DC cultures in the absence of antibiotics. After 2 h of incubation, gentamicin (50 g/ml) was added to the cultures and incubation was continued without removal of the bacteria for an additional 22 h. In control experiments, comparable IFN-␥ responses were observed when HMC cultures were instead stimulated with gentamicin-treated F. tularensis LVS or when no antibiotic was added to cultures challenged with live bacteria.
In experiments in which neutralizing anti-cytokine antibodies were tested, these antibodies were added immediately prior to the addition of the bacteria. By contrast, coactivating cytokines were added at the end of the initial 2-h challenge period with F. tularensis LVS. Culture supernatant fluids were collected 24 h later and stored at Ϫ70°C until assayed.
Cytokine immunoassays. Paired antibody sets and standards (BD Pharmingen) were used in enzyme-linked immunosorbent assays (ELISAs) to detect IFN-␥, IL-12p40, IL-12p70, and IL-18 in culture fluids. Absorbance was measured using a Biotek EL340 plate reader, and means and standard deviations for VOL. 75, 2007 TLR2 AND LYMPHOCYTE ACTIVATION BY F. TULARENSIS 5339 on September 22, 2017 by guest http://iai.asm.org/ triplicate samples were calculated from concentrations extrapolated from standard curves by DeltaSOFT II software. The limit of detection of each ELISA was approximately 5 pg/ml. According to the manufacturer, the assay for IL-12p40 detected all cytokines containing the p40 subunit, whereas the IL-12p70 assay was specific only for the p35p40 IL-12 heterodimer. The ELISA for IL-12p70 did not show a reaction with the IL-12p40 standard from the p40 ELISA kit. Likewise, cells from p35-deficient mice produced cytokines detectable by the IL12p40 but not the IL-12p70 ELISA. Statistical analysis. Each experiment was performed three times, and the most representative results are shown. Values shown are means and standard deviations. Analysis of variance (P Ͻ 0.05) was used to examine the differences between groups for all figures. For Fig. 8A , the comparison of responses in the presence of 30,000 cells was conducted by the two-sample t test.
RESULTS
HMC responses to F. tularensis LVS are augmented by M and DC. Mononuclear cells prepared from the livers of naïve B6 mice produced IFN-␥ in vitro when challenged with F. tularensis LVS organisms, and these responses were augmented by the addition of low concentrations (Ͻ10 pg/ml) of recombinant mouse IL-12 (Fig. 1A) . In a similar fashion, both bone marrow-derived M and DC provided coactivating signals for the IFN-␥ response to this pathogen. Significant augmentation was seen when as few as 10,000 M or DC were added to cultures containing 200,000 HMC. Both accessory cell populations decreased the number of bacteria that were necessary to activate HMC for IFN-␥ production and increased the magnitude of the response (Fig. 1B) . These properties are typical of coactivating cytokines, such as IL-12 and IL-18 (38) .
IL-12 mediates the coactivating properties of M and DC. To determine whether IL-12 or related cytokines played an essential role in the induction of IFN-␥ by M or DC, anti-IL-12 was added prior to challenging the cultures with F. tularensis LVS. As shown in Fig. 2 , anti-IL-12 inhibited the production of IFN-␥ by hepatic lymphocytes supplemented with bone marrow-derived M or DC, suggesting that IL-12 mediated the coactivating functions of these two accessory cell populations. In support of this finding, DC derived from p35-deficient mice showed a marked decrease in their ability to coactivate HMC for high-level IFN-␥ production (Fig. 3) , whereas p35-deficient M were indistinguishable from wildtype M in this regard. Differences between DC and M were also observed when their production of individual IL-12 subunits was measured (Fig. 4) . Both unstimulated M and DC constitutively produced relatively high levels of the IL-12p40 subunit, and this activity was increased following challenge with F. tularensis LVS (P Ͻ 0.05). By contrast, DC produced considerably higher levels of the IL-12p70 heterodimer than did M when both cell types were challenged with bacteria. The quantities of IL-12p70 produced by M varied from un- on September 22, 2017 by guest http://iai.asm.org/ detectable levels to several hundred picograms per ml but were always considerably less than the amounts produced by DC. Because the wild-type HMC used in the experiments whose results are shown in Fig. 3 could themselves produce IL-12p70 (38), we next evaluated IL-12 as a coactivating accessory cell signal, using HMC prepared from p35-deficient mice. In this fashion, only the accessory cells (i.e., M or DC) that were added to these HMC cultures could serve as a source of IL-12. When accessory cell function was evaluated in this manner, it was clear that both M and DC from wild-type mice strongly coactivated p35-deficient HMC for IFN-␥ production (Fig. 5) . By contrast, neither M nor DC from p35-deficient mice augmented the F. tularensis LVS-induced response. These observations established that the costimulatory activities of both M and DC were IL-12 dependent.
TLR2 mediates the recognition of F. tularensis LVS by DC and M but not the IFN-␥-producing cells.
A number of studies indicate that TLR2 is an important pattern recognition receptor mediating the recognition of F. tularensis LVS in mice (26, 28, 31) . As an initial approach to determining whether TLR2 similarly controlled the liver IFN-␥ response to this pathogen, HMC were prepared from wild-type, p35-deficient, and TLR2-deficient B6 mice and challenged with F. tularensis LVS in vitro. As can be seen in Fig. 6A , cells from mice deficient in either IL-12p35 or TLR2 failed to produce IFN-␥ when activated with viable bacteria. The addition of exogenous recombinant IL-12 restored the IFN-␥ responses of HMC from the two mutant strains and also enhanced the response by wild-type cells (Fig. 6B) , as was seen in Fig. 1A . These findings suggested that TLR2-deficient HMC lack the ability to produce sufficient quantities of IL-12 or cytokines with similar functions when stimulated with F. tularensis LVS.
To test this hypothesis, both M and DC were prepared from wild-type and TLR2-deficient mice and stimulated with bacteria. The production of IL-12p70, IL-12p40, and IL-18 was measured in culture fluids 24 h later. Similar to what was observed in Fig. 4 , wild-type DC, but not M, produced high levels of IL-12p70 (Fig. 7A) . However, DC prepared from TLR2-deficient mice produced only small amounts of the cytokine, indicating that TLR2 regulates the IL-12 response of DC to F. tularensis LVS. When the same culture fluids were analyzed for IL-12p40 as a control, both cell types from each strain of mice produced the subunit and did so over a wide range of MOI. Both wild-type DC and M produced IL-18 when activated with F. tularensis LVS (Fig. 7C) , but TLR2 appeared to regulate this response differently in the two cell types. Whereas TLR2-deficient DC showed greatly diminished IL-18 production, the absence of TLR2 did not significantly decrease IL-18 production by M.
Overall, these findings established a link between TLR2 on DC and the production of both IL-12 and IL-18 and suggested that TLR2 might regulate the IFN-␥ response by this mechanism. To test this hypothesis, TLR2-deficient M and DC were compared to wild-type accessory cells for their abilities to coactivate p35-deficient HMC that had been challenged with F. tularensis LVS. Whereas TLR2-deficient M showed a significantly decreased ability to coactivate HMC for IFN-␥ production (Fig. 8A ), they were significantly more active than IL12p35-deficient M in this regard. By contrast, TLR2-deficient DC were nearly inactive and appeared functionally equivalent to DC from IL-12p35-deficient mice. The defects of both p35-deficient and TLR2-deficient DC in these cultures could be completely restored by adding exogenous recombinant IL-12 to the cultures (Fig. 8B) . These findings support the conclusion that TLR2 regulates DC costimulatory activity by controlling IL-12p70 production. The data also indicate that TLR2-deficient M produce IL-18 in response to F. tularensis LVS (Fig.  7C ) and show costimulatory activity for the IFN-␥ response (Fig. 8A) . Another potential mechanism for explaining the function of TLR2 in the IFN-␥ response was considered, namely, that TLR2 mediates the recognition of F. tularensis LVS by the IFN-␥-producing cells themselves. However, TLR2-deficient HMC produced levels of IFN-␥ that were comparable to those for wild-type HMC when either of these types of cells was cocultured with wild-type M or DC and activated with F. tularensis LVS (Fig. 9) . Thus, TLR2 appeared to control IFN-␥ production by regulating IL-12 and IL-18 production rather than by controlling the ability of IFN-␥-producing cells to recognize the pathogen using TLR2.
DISCUSSION
Regardless of the route of infection with F. tularensis, the liver is a common site of secondary bacterial colonization, which is thought to result from the hematogenous spread of the organism. The greatest expression of proinflammatory mRNA for cytokines and chemokines during infections with F. tularensis LVS in mice also occurs in the liver (9) . mRNA for some of these mediators appears in the mouse liver within hours after systemic challenge with F. tularensis LVS (9). Because IFN-␥-deficient mice are highly susceptible to F. tularensis LVS challenge by the intradermal and intrapulmonary routes (7, 11, 17) and have difficulty clearing the organism from their livers (7), we have performed a number of experiments designed to elucidate the cellular requirements for hepatic IFN-␥ production in response to infection. The livers of uninfected mice contain large numbers of NK, NKT, and T cells, and each of these lymphocyte populations becomes activated for IFN-␥ expression following intranasal (S. M. Bokhari, K.-J. Kim, D. M. Pinson, J. Slusser, J. R. Wickstrum, H.-W. Yeh, and M. J. Parmely, submitted for publication) or intraperitoneal (38) challenge with F. tularensis LVS. Likewise, the same responding lymphocyte subsets can be activated with F. tularensis LVS in vitro (data not shown). In infected mice lacking a functional IL-12p35 gene, IFN-␥ expression was not seen in any of the lymphocyte subsets that are activated in wild-type mice (38) .
Mononuclear cells prepared by enzymatic digestion of the liver include large numbers of mononuclear phagocytes (Kupffer cells) and several subsets of DC (25, 29) . However, prior to this study it was not known whether M or DC promoted hepatic IFN-␥ responses to F. tularensis and whether they did so by secreting IL-12. IL-12 is a 70-kDa heterodimer composed of p40 and p35 subunits and can coactivate both NK cells and T cells for IFN-␥ production (4, 36) . Previous studies conducted in our laboratory (38) have shown that IL-12 coactivates F. tularensis LVS-stimulated hepatic lymphocytes for IFN-␥ production in vitro and that the IL-12p35 subunit is essential for this response. Mouse recombinant IL-18 also promoted IFN-␥ production and acted synergistically with IL-12. Remarkably low concentrations of IL-12 (1 to 10 pg/ml) were sufficient to increase significantly the F. tularensis LVS-induced IFN-␥ response in vitro. The mouse liver appears to be the predominant site of IL-12p35 expression during systemic infections with F. tularensis LVS (9), and HMC from uninfected mice express IL-12p70 when activated with F. tularensis LVS in vitro (38) . Although activated bone marrow-derived DC in the present study produced large amounts of the IL-12p70 heterodimer when stimulated with F. tularensis LVS, similarly activated M did not consistently produce equivalent amounts of IL-12. This raises the question of why M-mediated coactivation was found to be IL-12 dependent ( Fig. 3 and 8 ). As noted above, some IFN-␥-inducing cytokines, such as IL-18, synergize with IL-12 (34, 39 IL-12. Consistent with this conclusion is the finding that neutralizing concentrations of either anti-IL-12 or anti-IL-18 reversed the coactivating effects of M on the HMC IFN-␥ response to F. tularensis LVS (Fig. 2) (38) . Whatever the mechanism, it is clear from the current studies that, unlike DC, M do not require TLR2 to produce IL-18 or coactivate F. tularensis LVS-stimulated HMC cultures for IFN-␥ production. Previous reports have indicated that F. tularensis LVS-activated mouse DC populations express costimulatory properties. Katz et al. (26) noted that bone marrow-derived mouse DC produced IL-12p40, TNF-␣, and IL-6 when stimulated in vitro with F. tularensis LVS, and the induction of both these cytokines and cell surface costimulatory molecules (e.g., CD86) were TLR2 dependent. Similarly, Ben Nasr et al. (3) reported that human monocyte-derived DC produced TNF-␣ and IL12p70 when activated with F. tularensis LVS in vitro, and Li et al. (28) showed that F. tularensis LVS stimulated the expression of IL-1␤ and TNF-␣ mRNA by mouse bone marrowderived DC. By contrast, Bosio and Dow (5) did not detect TNF-␣, IL-6, or IL-10 production in mouse bone marrowderived DC cultures that had been stimulated with F. tularensis LVS, despite an increase in the expression of CD86 and MHC class II molecules induced by these cells. One explanation for the differences between this report and our current findings is the level of maturation of the DC populations in the two studies. We have found that the ability of bone marrow-derived DC to produce IL-12p70 and coactivate the IFN-␥ response to F. tularensis LVS required at least 12 days of DC differentiation from bone marrow cells. The DC studied by Bosio and Dow (5) were derived after only 8 days of culture.
Malik et al. (31) reported that TLR2-deficient mice, when infected with F. tularensis LVS by the intranasal route, showed significantly elevated levels of IFN-␥ in lung homogenates compared to wild-type-infected mice. This result would seem inconsistent with our finding that cells from the livers of naïve uninfected mice do not produce the cytokine when activated with F. tularensis LVS in vitro. Two potential explanations exist for this apparent discrepancy. First, it may be that cells that are essential to the IFN-␥ response but are not present in the uninfected liver are attracted to the liver during infection. Second, key coactivating cytokines that arrive via the blood and promote the hepatic IFN-␥ response may be produced at tissue sites distant from the liver in TLR2-deficient mice.
The current study suggests that the nature of the responding cell determines the role, if any, of a particular microbial pattern recognition receptor. Whereas TLR2 plays a significant role in the recognition of F. tularensis LVS by a number of mouse DC and M populations (10, 26, 28, 31) , TLR2-independent pathways for activating M with this pathogen have also been identified here.
